Market Place
Sourcing Support
OBiO Supports First Clinical Gene Editing By CorrectSequence
06 Aug 2024 //
PRESS RELEASE
Three Benefits Of Partnering With A CDMO For Cell And Gene Therapy Manufacturing
15 Jun 2024 //
PRESS RELEASE
OBiO Launches Pediatric Rare Disease Advanced Therapy Translation Center
30 May 2024 //
PR NEWSWIRE
Meet OBiO Technology at ASGCT 2024! May 7th to 11th
27 Apr 2024 //
PRESS RELEASE
Dynamic Partnership Between OBiO Technology
03 Apr 2024 //
PRESS RELEASE
The 2024 Cell and Gene Therapy Workshop, "Horizons Unveiled
03 Apr 2024 //
PRESS RELEASE
Breaking News: OBiO Technology and Novabio Therapeutics Join Forces
25 Mar 2024 //
PRESS RELEASE
Embark on a Journey to `Cure the Future` with Dr. Pan,chairman of OBiO
17 Mar 2024 //
PRESS RELEASE
We are thrilled to introduce Hung Trinh, who has joined OBiO Tech our Sr BD Dir
02 Mar 2024 //
PRESS RELEASE
Please join us in welcoming Swati to OBiO Tech
16 Feb 2024 //
PRESS RELEASE
Discover the Ultimate One-Step Method to Perfectly Cultivate Prokaryotic Cells
06 Feb 2024 //
PRESS RELEASE
Focusing on efficient gene delivery of NK cells, First Condor Life & OBiO Tech
13 Jan 2024 //
PRESS RELEASE
OBiO Announces Strategic Partnership with Refreshgene
24 Oct 2023 //
PR NEWSWIRE
OBiO has launched its state-of-the-art GMP production facility
27 Sep 2023 //
PR NEWSWIRE
FDA Acceptance of Drug Master File Marks Milestone Achieved for OBiO TECH
29 Jun 2023 //
PRESS RELEASE
OBiO Technology Adds Univercells Upstream Platform for Gene Therapy Mfg.
28 Jun 2023 //
CONTRACT PHARMA
OBiO & CHINAGENE reached a strategic agreement of commercial mfg services
29 Apr 2023 //
PR NEWSWIRE
A factory with 29 GMP grade production lines for gene therapy was launched
24 Apr 2023 //
PRESS RELEASE
FDA Accepts GMP Plasmid DMF of OBiO Technology
16 Jan 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.